Independent Director · PUMA BIOTECHNOLOGY, INC. (PBYI)

Chair, Research and Development Committee

Adrian M. Senderowicz, M.D — PUMA BIOTECHNOLOGY Director Compensation (2025)

Fiscal year 2025 director compensation for Adrian M. Senderowicz, M.D at PUMA BIOTECHNOLOGY, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Track this executive's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat

A confirmation now and one email when Pro opens, and nothing else. Privacy

What they were paid

PUMA BIOTECHNOLOGY Director Compensation Table · all 2 fiscal years held
In US dollars, as PUMA BIOTECHNOLOGY reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,000$95,580$0$0$165,580
FY2024$70,000$83,430——$153,430

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PUMA BIOTECHNOLOGY, INC. DEF 14A filed April 28, 2026, accession 0001437749-26-013671, and prior-year filings. Open the filing on EDGAR.

That is Adrian M. Senderowicz, M.D’s FY2025 figure, as filed. The FY2026 figure the day it is filed: one email, nothing else.

Saved. One email when Adrian M. Senderowicz, M.D’s next annual disclosure lands here, with the figure.

One email when Adrian M. Senderowicz, M.D’s next annual disclosure is on this page, with the figure. Nothing else is sent.

Get the PUMA BIOTECHNOLOGY Board Governance Report

$165,580 Adrian M. Senderowicz, M.D, FY2025 total director compensation

$499

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

PUMA BIOTECHNOLOGY pays directors a $50,000 cash retainer and $95,580 in equity.

Committees

FY2025 · as the proxy prints them

Nominating/Governance · Research and Development (Chair)

The rest of the PUMA BIOTECHNOLOGY board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alan H. AuerbachChair of the Board—
Alessandra Cesano, M.D., Ph.DIndependent Director$153,080
Allison DorvalIndependent Director$155,580
Brian Stuglik, R.PhIndependent Director$168,080
Jay M. MoyesLead Independent Director$173,080
Michael P. MillerIndependent Director$158,080
Troy E. Wilson, Ph.D., J.DIndependent Director$173,080

The full PUMA BIOTECHNOLOGY compensation record

free company brief

This page is one director within PUMA BIOTECHNOLOGY's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the PUMA BIOTECHNOLOGY proxy · each links to its own free brief

Order PBYI

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report